ESC Premium Access

SGLT2 inhibitors and atherosclerosis-related outcomes: the good and the bad

Congress Presentation

About the speaker

Professor Anna Norhammar

Karolinska Institute, Stockholm (Sweden)
4 presentations
0 follower

3 more presentations in this session

SGLT2 inhibitors and heart failure: expensive diuretics or added value?

Speaker: Doctor M. Kosiborod (Kansas City, US)

Thumbnail

SGLT2 inhibitors: is the benefit related to renal outcomes?

Speaker: Professor A. Ceriello (Milan, IT)

Thumbnail

Panel discussion: how should cardiologists use SGLT2 inhibitors in clinical practice?

Thumbnail

Access the full session

SGLT2 inhibitors and cardiovascular outcomes

Speakers: Professor A. Norhammar, Doctor M. Kosiborod, Professor A. Ceriello
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by